This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Microcurrent Stimulation to Treat Macular Degeneration

This study has been completed.
Information provided by (Responsible Party):
Retina Institute of Hawaii Identifier:
First received: February 11, 2013
Last updated: NA
Last verified: February 2013
History: No changes posted
Microcurrent stimulation thereapy improves retinal efficiency and may restore and/or improve retinal function.

Retinal Diseases Stargardt's Disease Retinitis Pigmentosa

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Retrospective
Official Title: An Observational, Multi-Center Phase 1 Study of the Safety and Effectiveness of Frequency Specific Microcurrent Stimulation as an Alternative Treatment for Retinal Diseases

Resource links provided by NLM:

Further study details as provided by Retina Institute of Hawaii:

Primary Outcome Measures:
  • Measure visual acuity after receiving microcurrent stimulation treatments. [ Time Frame: 6 months ]

Enrollment: 50
Study Start Date: June 2012
Study Completion Date: December 2012
Primary Completion Date: December 2012 (Final data collection date for primary outcome measure)
Detailed Description:
This is an observational study in which data will be collected from a group of patients with retinal diseases such as Dry Macular Degeneration, RetinitisPigmentosa, and Stargardt's Disease, who have opted to receive Microcurrent Stimulation Therapy as an alternative treatment for their retinal condition.

Ages Eligible for Study:   50 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Patients with retinal disease such as Age-Related Macular Degeneration, STargardt's Disease, and Retinitis Pigmentosa

Inclusion Criteria:

  • Ability to provide written consent and comply with follow up visits
  • Age 40 years or older
  • ETDRS best corrected visual acuity better than 5 letters
  • History of Dry Age Relted Macular Degeneration; Retinitis Pigmentosa; Stargardt's disease
  • No Anti-VEGF treatments for at least 3 months prior to study
  • No new antioxidant/vitamin supplementation for at least 3 months prior to study

Exclusion Criteria:

  • History of Non-Compliance with regular medical visits
  • Significant media opacities (exclude NS 4+) that may interfere with assessing visual acuity
  • Presence of pigment epithelial tears or rips
  • Known serious allergies to fluorescein dye
  • Presence of retinal neovascularization
  • Any treatment with an investigation agent in the past 30 days
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01790958

United States, Hawaii
Hawaii Cataract Laser Institute - Hilo
Hilo, Hawaii, United States, 96720
Retina Institute of Hawaii
Honolulu, Hawaii, United States, 96815
Hawaii Cataract Laser Institute - Maui
Kahului, Hawaii, United States, 96732
Hawaii Cataract Laser Institute - Kona
Kailua-Kona, Hawaii, United States, 96740
Sponsors and Collaborators
Retina Institute of Hawaii
Principal Investigator: George Papastergiou, MD Retina Institute of Hawaii
  More Information

Responsible Party: Retina Institute of Hawaii Identifier: NCT01790958     History of Changes
Other Study ID Numbers: RIH 1009
Study First Received: February 11, 2013
Last Updated: February 11, 2013

Additional relevant MeSH terms:
Retinitis Pigmentosa
Retinal Diseases
Eye Diseases
Eye Diseases, Hereditary
Retinal Dystrophies
Retinal Degeneration
Genetic Diseases, Inborn processed this record on August 18, 2017